The treatment part of this Phase 1 clinical trial for kidney cancer is over, now we’re in the watching and waiting phase.

My husband, Ralph, is patient #3 in a first in human clinical trial for kidney cancer at NIH.  He was diagnosed with stage IV Kidney Cancer in 2014. His journey has been long and somewhat difficult. This is his 4th clinical trial and 8th treatment regime.

A little over a week ago he had new fighter T-cells infused.  These new T-cells are modified to identify and attack his tumor cells.  At least, that’s what they did in the lab.  We’re waiting to see if they behave like that in Ralph’s body.

He was released after 12 days in the hospital.  Overall, he did very well tolerating the treatment which included 13 doses of IL-2.  His team of about 20 doctors are very pleased and relieved.  They really did not think he could tolerate that many IL-2 treatments since his heart is compromised.  However, he was released on oxygen which is likely temporary and a result of the IL-2 treatment.

Over the next several weeks, we’ll continue to stay in the downtown Bethesda area which has great places to eat (and shop) all within walking distance to our hotel.  He’ll have follow-up visits at NIH to include lab work, etc.  After all, they want to keep a close eye on their patient and their experiment.

WHO WE ARE →

WHAT WE DO →

OUR STORIES →

THE KIDNEY CANCER COMMUNITY →

SCIENTIFIC ADVISORY BOARD →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

JOIN OUR COMMUNITY →

RAISING AWARENESS →

BE AN ADVOCATE →

DISTRICT DAYS →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

FACING KIDNEY CANCER →

DIAGNOSIS →

BUILDING A CARE TEAM →

LEARN ABOUT CLINICAL TRIALS →

LIVING WELL WITH KIDNEY CANCER →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...

KCRS →

RESEARCH OPPORTUNITIES →

ADVOCATE WITH KIDNEYCAN →

KIDNEYCAN NEWS →

DONATE →

CONTACT →

Latest News

Dr. John T. Wilson: “A Lot of Reason to Hope”

Dr. John T. Wilson: “A Lot of Reason to Hope”

Researcher Spotlight: Dr. John T. Wilson Giving Patients "A Lot of Reason to Hope" At KidneyCAN, we have the pleasure of meeting and working with talented researchers from all over the world. We want to share some of the insights and experiences of one such researcher today, Dr. John T. Wilson,...

SUPPORT OUR WORK →

FUNDRAISE FOR KIDNEYCAN →

DONATE →

CONTACT →

Latest News

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

World Kidney Cancer Day 2021: We Need to Talk About How We’re Feeling

On June 17th, people from all around the world came together to participate in activities for #WorldKidneyCancerDay, and we’re proud to share what KidneyCAN did in partnership with the IKCC and many other partners from the kidney cancer community. Our goal each year on World Kidney Cancer Day is...